While GCSF has been reported to increase PD-L1 expression on neutrophils and contribute to increased tumour shrinkage in cancers with GCSF expression, further research on the effects of GCSF prophylaxis on these and the duration of these effects is required [7]. The gene discussed is CD274; the disease is neoplasm.